News & insight.

U of A Researcher Urges Routine Deprescribing Reviews to Reduce Polypharmacy Harm

OCP adds ISMP agreement workflow to Ontario’s AIMS rollout

Ontario’s College says designated managers can now complete the ISMP Canada data-sharing agreement through an automated process. Its updated criteria also list platforms currently testing, while pharmacies still need a compliant incident-management system by January 1, 2027.

Health Canada Database Lists Trimbow as Marketed in Canada

Health Canada’s Drug Product Database now records the triple-combination COPD inhaler Trimbow as marketed, with a status date of September 24, 2026. The product was authorized in May 2025; the new database status is a market-availability signal, not a new approval or confirmation of public coverage. The update is a timely prompt for pharmacists to review its COPD-only indication, place in therapy, and inhaler counselling points.

Manitoba Regulator Orders Fine and Practice Limits After Pharmacy Oversight Admissions

A College of Pharmacists of Manitoba discipline decision details a pharmacy manager’s guilty plea to 10 counts involving dispensing, controlled-drug records and inventory oversight. The panel ordered a $15,000 fine, a two-year restriction on serving as a preceptor, and a routine inspection of the pharmacy. It also distinguished the manager’s admitted oversight failures from a staff pharmacist’s independent actions that left thousands of doses unaccounted for.

U.S. Recarbrio Withdrawal Raises Antibiotic Access Questions; Canada Still Lists It as Marketed

Merck is withdrawing Recarbrio from the U.S. market, while Health Canada’s database still lists the product as marketed. Canadian supply cannot be inferred from either fact alone.

Health Canada Recalls One PMS-FAMPRIDINE Lot Over Possible Foreign Particles

One lot of PMS-FAMPRIDINE 10 mg tablets (DIN 02496216, lot 24123884) is under a retailer-level recall. Verify the lot and guide patients without abruptly interrupting care.

From Medication Incidents to Learning: ISMP Webinar Set for October 28

An October 28 ISMP Canada webinar will connect patient experience with incident analysis, giving pharmacy teams a practical focus for safety discussions.

Mounjaro KwikPen “Click Counting”: The Arithmetic, the Limits and the Safety Conversation

Kratom Safety Questions Resurface as Health Canada Reiterates Products Are Unauthorized

Northern Ontario Police Report More Diverted Prescription Opioids in Drug Investigations

Okotoks Pharmacy Replaces Blame With Learning to Strengthen Patient Safety

An Alberta College of Pharmacy profile shows how licensee Yasmin Mohamed Essa built a just culture around incidents and close calls: protect the patient first, examine system causes, report promptly, and turn team discussion into practical workflow changes.